InsidersTradesSigma
Follow the Telo Genomics Corp. share price and the full management transaction log of the company, a publicly traded company based in Canada. Shares are quoted on CA CA, under the authority of SEDI. Market capitalisation: €4m. The latest transaction was disclosed on 25 June 2026 (50 - Grant of options). Among the most active insiders: Farlinger, John Allen. The full history is openly available.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
2 of 2 declarations
Telo Genomics Corp. is a biotechnology company focused on developing diagnostic tests based on telomerase for cancer. It is listed on the XTSE.